What People With IBD Need to Know About COVID-19

If you live with inflammatory bowel disease (IBD)Crohn’s disease or ulcerative colitisCOVID-19 can feel like an extra boss level you didn’t ask to unlock.
The good news: most people with IBD are not automatically doomed to worse COVID outcomes just because they have IBD. The tricky part is that the details
matter: your age, other health conditions, how active your IBD is, and which medications you take can change the math.

This guide breaks down what the current evidence and major U.S. health organizations generally agree on, plus practical “what do I do on Tuesday morning” tips.
It’s written for real lifewhere you might be juggling biologic infusions, a job that still expects you to “circle back,” and a gut that can’t decide if it’s
team diarrhea or team constipation.

Quick note: This is educational information, not personal medical advice. Your GI team knows your history, your meds, and your risk profilelean on them.

1) Are people with IBD at higher risk from COVID-19?

IBD alone usually isn’t the main villain

Large real-world data sets have generally found that having IBD by itself doesn’t automatically raise the risk of severe COVID-19 compared with the general population.
Instead, outcomes tend to track with the same risk factors as everyone else: older age, heart/lung disease, diabetes, obesity, kidney disease, and so on.

What can raise risk: active inflammation and certain medications

Two IBD-specific factors come up again and again:

• Active IBD (especially moderate-to-severe disease)because uncontrolled inflammation can weaken your overall resilience.
• Systemic steroids (like prednisone)which are consistently linked to worse COVID outcomes in IBD populations.

Translation: If your IBD is flaring hard, or you’re on systemic steroids, it’s worth being extra proactive about prevention, vaccination, and early treatment.

2) Your IBD medications and COVID-19: what the data suggests

Here’s the best “plain-English” way to think about it: many maintenance IBD medications are designed to reduce harmful inflammation in a targeted way. That’s not the same
as “your immune system is turned off.” But some therapies do affect infection risk and vaccine response, and a few have been associated with more severe COVID outcomes.

Systemic corticosteroids (prednisone and friends)

If COVID-19 had a “most wanted” list for IBD patients, systemic steroids would be on the poster. Across multiple studies and registry analyses, steroid use is linked with
higher odds of severe COVID-19. If you’re on steroids, ask your GI team about a steroid-sparing plan whenever possible (sometimes that means adjusting maintenance therapy,
adding rectal/topical therapy, or changing biologicsdepending on your situation).

Biologics (anti-TNF, vedolizumab, ustekinumab, IL inhibitors, etc.)

Many biologics have not shown a clear signal of worse COVID-19 outcomes in IBD populations. That’s one reason GI societies have often emphasized staying on effective
maintenance therapy: uncontrolled IBD can land you in the hospital (and nobody wants extra hospital time during a respiratory virus surge).

A practical takeaway many clinicians use: if your biologic is keeping you stable, the risk of stopping it abruptlytriggering a flare, needing steroids, or losing response
can be worse than the infection risk you’re trying to avoid.

Thiopurines and methotrexate (immunomodulators)

Some data suggest certain immunomodulatorsespecially in specific combinationsmay be associated with higher risk of severe outcomes compared with some other IBD therapies.
This doesn’t mean “panic and quit.” It means you should:

• Make sure your vaccination plan is up to date.
• Have a “call us immediately if you test positive” plan with your GI team.
• Discuss whether your current regimen is still the best long-term fit for you (risk/benefit is individual).

JAK inhibitors (example: tofacitinib)

JAK inhibitors can affect immune signaling broadly. Many clinicians treat them similarly to other higher-impact immune-modifying meds: stay protected, monitor closely, and
if you get COVID-19, talk with your GI team right away about temporary holds and treatment options.

5-ASA (mesalamine) and other gut-targeted therapies

5-ASA is not generally considered a major driver of severe COVID-19 risk the way systemic steroids are, and it’s commonly used as a maintenance therapy. If it’s part of
your regimen, keep taking it unless your clinician tells you otherwise.

3) Vaccines and boosters: the IBD-friendly game plan

Yes, vaccination is still a big dealespecially if you’re higher risk

Major GI organizations and patient advocacy groups have consistently supported COVID-19 vaccination for people with IBD. Why? Because the vaccines reduce the risk of severe
disease, hospitalization, and deathparticularly in higher-risk groups.

“But will the vaccine cause an IBD flare?”

Most people with IBD do not report significant flare problems after vaccination. Some experience short-term side effects (fatigue, fever, aches, sore arm), which can
feel suspiciously like “my immune system is planning something.” Usually it’s just your body practicing for the real thing.

If you’ve had flares with vaccines before, or you’re currently in a flare, ask your GI team about timing. In many cases, vaccination is still recommendedsometimes with
extra planning (hydration, rest, symptom monitoring, and a low threshold to reach out if GI symptoms spike).

If you’re immunocompromised, your schedule may differ

The U.S. vaccination approach continues to evolve. Recent CDC guidance has included specific recommendations for people who are moderately or severely immunocompromised,
which can involve more than one dose of the current-season vaccine depending on prior vaccination history and shared clinical decision-making.

Practical tip: Don’t guess whether you “count” as immunocompromisedask. Your medication list matters. Your GI team or pharmacist can help match your situation to current
recommendations.

Will my IBD meds reduce vaccine protection?

Some immune-modifying therapies can reduce antibody responses. That doesn’t mean vaccination is pointless; it means you may benefit from:

• Staying current with recommended doses
• Layering protection during surges (masking in crowded indoor spaces, ventilation, avoiding exposure when possible)
• Having an early-treatment plan if you test positive

4) If you get COVID-19: a step-by-step playbook for people with IBD

Step 1: Don’t “wait it out” if you’re higher risk

COVID-19 treatments work best when started earlyoften within the first 5–7 days of symptoms, depending on the medication. If you’re older, have comorbidities, are on
systemic steroids, or take certain immune-modifying meds, call your healthcare team promptly.

Step 2: Tell your GI team you tested positive

Many GI groups have advised that if an IBD patient develops symptomatic COVID-19, certain medications may be temporarily held during the viral illnessparticularly some
immunomodulators, JAK inhibitors, and biologicsthen restarted after recovery. This is individualized. The goal is to reduce risk during active infection without triggering
an IBD flare.

Important: Don’t stop your meds without guidance. A flare can lead to steroids or hospitalizationboth of which can make everything harder.

Step 3: Ask about antiviral treatment (especially Paxlovid)

For eligible higher-risk patients, oral antiviral treatment (like Paxlovid) can lower the risk of hospitalization and severe outcomes if started quicklytypically within
five days of symptom onset. Some IBD-focused guidance notes benefits for people with IBD who qualify.

Other options may include intravenous remdesivir given early in infection for certain high-risk patients when Paxlovid isn’t appropriate.

Step 4: Watch out for drug interactions (this is not optional)

Paxlovid contains ritonavir, which can strongly interact with many medications. Some interactions can be serious. If you take immunosuppressants like tacrolimus or
cyclosporine (less common in IBD, but sometimes used), interactions are especially important. Even if you don’t, you may have interactions with other meds
(cholesterol meds, certain heart rhythm drugs, some seizure meds, and more).

Bottom line: bring a complete medication list to the conversationprescriptions, OTC meds, supplements, everything. Your pharmacist is your MVP here.

Step 5: Treat symptoms smartlyand protect your gut

• Hydration: fever + diarrhea is a dehydration tag-team. Prioritize fluids and electrolytes.
• Nutrition: small, gentle meals; don’t force “clean eating” heroics when you’re sick.
• Fever/pain: use what your clinician says is safe for you (some people with IBD avoid NSAIDs; ask if you’re unsure).
• Monitor red flags: shortness of breath, chest pain, confusion, dehydration, severe weakness, persistent high fever, or worsening abdominal pain/bleeding.

5) Prevention without turning into a hermit

You don’t need to live inside a bubble (unless it has great Wi-Fi and snacks). A practical strategy is “layered protection”using multiple modest steps that add up.

Layer 1: Vaccination

Stay current with the most recent recommended vaccine for your risk group. If you’re on immune-modifying therapy, consider vaccination a foundationnot the only tool.

Layer 2: Ventilation and crowd strategy

COVID spreads most easily in crowded indoor spaces with poor ventilation. If you’re higher risk:

• Prefer outdoor meetups or well-ventilated indoor spaces
• Avoid peak crowd times when possible
• Crack windows, use HEPA air filters, and aim for airflow (yes, airflow is sexy now)

Layer 3: Masking when it matters

Masking can still make sense for higher-risk IBD patients during surges, in healthcare settings, or in crowded indoor places (airports, planes, concerts, packed offices).
Think of it like bringing an umbrella: you don’t need it every day, but you’ll be glad you had it when the forecast turns.

Layer 4: Testing and timing

If you feel sick, test earlyespecially if you’d qualify for antivirals. Timing matters. Early testing can turn “I’ll just rest this weekend” into “I started treatment
on day 2 and avoided a hospital visit.” That’s a pretty good trade.

6) Work, school, travel, and medical appointments: practical IBD tips

Infusions and clinic visits

Many infusion centers have strong infection-control practices. If you’re anxious, ask what they do: screening, masking policies during surges, ventilation, and protocols
for sick staff/patients. Planning reduces stressand stress is already on your gut’s “Do Not Invite” list.

Travel

• Pack extra meds in carry-on baggage (delayed luggage is not a personality trait you want to develop).
• Bring rapid tests and a mask for crowded indoor situations.
• Know how to access care at your destination (urgent care, telehealth, pharmacy).
• If you’re higher risk, ask your clinician about an “if I test positive” plan before you leave.

Returning to normal activities after illness

Public health guidance has shifted over time toward staying home while you’re clearly sick, then returning to normal activities once symptoms are improving and you’ve been
fever-free for at least 24 hours (without fever-reducing meds), while taking extra precautions for a short period to protect othersespecially vulnerable people.

7) Long COVID and IBD: what to watch for

Long COVID (post-acute symptoms lasting weeks to months) can affect many systems: fatigue, brain fog, shortness of breath, sleep disruption, and GI symptoms. If your gut
symptoms change after COVID, it can be hard to tell whether it’s long COVID, an IBD flare, stress effects, or a medication issue.

A helpful approach is to track symptoms objectively for a couple weeks (stool frequency, bleeding, pain, fever, weight, fatigue), then share the pattern with your GI team.
That gives you a clearer path to the right labs, stool tests, or imagingrather than guessing and spiraling on the internet at 2 a.m. (we’ve all been there).

8) Frequently asked questions (answered like a human)

Should I stop my IBD meds to avoid getting COVID?

Usually, no. Stopping effective maintenance therapy can trigger a flare and increase the chance you’ll need systemic steroids or hospitalizationboth of which can raise risk.
Talk to your GI team if you’re concerned, especially if your regimen includes systemic steroids, certain immunomodulators, or JAK inhibitors.

If I test positive, do I automatically stop my biologic?

Not automatically. Many guidance statements suggest holding certain therapies during active symptomatic infection, but the decision depends on your symptoms, your IBD activity,
and your risk factors. Your GI team can tell you what to do and when to restart.

Is Paxlovid safe if I have IBD?

Many people with IBD can take it if they qualify, but drug interactions are the headline. Always review your medication list with a clinician or pharmacist before starting.

Can COVID itself trigger a flare?

Viral infections and stress can aggravate GI symptoms in some people. COVID can also cause GI symptoms that mimic flares. If symptoms persist or you see bleeding, contact your
GI teamdon’t assume it’s “just the virus” or “just my IBD” without checking.

9) The bottom line

If you have IBD, your best COVID strategy is boringbut powerful:

• Keep your IBD controlled (because active disease and steroid use are not your friends).
• Stay up to date on vaccination based on your age, risk factors, and current guidance.
• Have an early-treatment plan (know who to call and whether you may qualify for antivirals).
• Use layered prevention when risk is higher (crowds + indoor + poor ventilation = consider masking).
• Don’t make medication changes aloneyour GI team is part of your immune system now.

COVID-19 is no longer “new,” but it’s still realespecially for people with higher-risk medical situations. With the right plan, you can protect your health without
putting your life on indefinite pause.

Real-World Experiences: What People With IBD Say Helped

The stories below are composite experiences based on common themes patients report in clinics and IBD communitiesshared here to illustrate practical
lessons, not as official medical advice.

1) “I was stable on a biologicso I stopped doom-scrolling and stayed the course.”

One common experience: people who were doing well on maintenance therapy (often a biologic) felt tempted to “pause” meds when COVID surged. But after talking with their GI
team, many chose consistency over improvisation. The relief wasn’t just medicalit was emotional. They stopped playing medication roulette and focused on controllables:
staying vaccinated, avoiding packed indoor events during surges, and keeping rapid tests at home.

The biggest lesson patients often share: stability is protective. When your IBD is calm, you’re less likely to end up needing steroids or emergency care at the exact
moment you want to avoid extra exposures.

2) “Prednisone and COVID felt like the worst crossover episode.”

Another frequent theme: people who caught COVID while on systemic steroids often described a rougher ridemore fatigue, a longer recovery, and higher anxiety. The most helpful
move wasn’t pretending everything was fine; it was acting early. Many said they wished they had called sooner to ask about antivirals, or they were glad they did because
treatment had a clear “I’m turning a corner” moment.

A practical takeaway patients repeat: if you’re on prednisone (or just finished a course) and you test positive, treat it like a “call today” situation, not a “maybe next week”
situation.

3) “My COVID symptoms looked like a flareuntil the test proved otherwise.”

GI symptoms during COVID are real. People with IBD often describe the mental tug-of-war: “Is this my disease or the virus?” Many found it helpful to use a simple tracker for
7–14 days: stool frequency, blood, abdominal pain, temperature, and energy level. Having that data made conversations with clinicians quicker and more accurateless vague
“my stomach feels weird,” more “I’m up from 3 stools/day to 8, and bleeding started on day 4.”

Several patients say the tracker helped them avoid two extremes: ignoring a real flare or overreacting to temporary viral GI symptoms that improved with rest and hydration.

4) “My ‘COVID kit’ reduced panic more than anything else.”

A surprisingly powerful coping strategy was preparing a small home kit. People often mention:

• Rapid tests
• Electrolyte packets or oral rehydration solution
• A thermometer and pulse oximeter
• Easy foods they tolerate during flares (rice, broth, bananas, applesauce, toast, or their personal safe list)
• A written note with: GI office number, pharmacy number, and “am I a candidate for antivirals?” reminders

The kit didn’t prevent infection. But it prevented the spiral of “What do I do now?” when symptoms hit, especially at night or on weekends.

5) “Boundaries became a health tool.”

People with IBD often report that social pressurenot medical factswas the hardest part. Some learned to say, “I’m not doing crowded indoor dining right now,” without
apologizing like they’d committed a felony. Others chose a middle path: meet outdoors, keep gatherings smaller, or mask in tight indoor spaces during surges.

Many describe it as reclaiming control: instead of trying to predict every variant and headline, they picked a few consistent rules that fit their risk level and mental
health. The most common “win” wasn’t perfectionit was sustainability.

If there’s a unifying message from these experiences, it’s this: a plan beats panic. Knowing your risk factors, staying stable on effective IBD therapy, keeping vaccination
current, and acting early for treatment can turn COVID from a terrifying unknown into a manageable (if still annoying) event.